Loren Data's SAM Daily™

SAMDAILY.US - ISSUE OF NOVEMBER 04, 2022 SAM #7644
SPECIAL NOTICE

65 -- Pfizer PAXLOVID COVID-19 Therapeutic

Notice Date

11/2/2022 10:28:52 AM
 

Notice Type

Special Notice
 

NAICS

325412 — Pharmaceutical Preparation Manufacturing
 

Contracting Office

DEPT OF THE ARMY
 

ZIP Code

00000
 

Solicitation Number

W58P0522C0001P00005
 

Response Due

11/9/2022 12:00:00 PM
 

Point of Contact

Danny Soto, Robin Bronson
 

E-Mail Address

danny.soto3.civ@army.mil, robin.l.bronson.civ@army.mil
(danny.soto3.civ@army.mil, robin.l.bronson.civ@army.mil)
 

Description

The U.S. Army Contracting Command � Joint COVID-19 Response Division, 6472 Integrity Court (Building 4401), Aberdeen Proving Ground, MD 21005-3013 has a sole source requirement on behalf of the Department of Health and Human Services (DHHS) (collectively, the Government or USG) to procure up to 3.7 million treatment courses (TC) of Pfizer�s oral antiviral therapeutic, PAXLOVID, to treat the US general population in response to the SAR-CoV-2 Virus.� ��� This acquisition will be conducted as a sole source contract to Pfizer Inc., 235 E. 42nd St, New York, New York, 10017-5703, IAW FAR 6.302-1.� The USG anticipates awarding a firm fixed price contract modification with a period of performant of 81 months.� Interested parties who believe they have a basis for providing Pfizer�s oral antiviral therapeutic PAXLOVID product, or have other questions pertaining to this acquisition, may contact Danny Soto at dany.soto3.civ@army.mil and Robin Bronson at robin.l.bronson.civ@army.mil� �
 

Web Link

SAM.gov Permalink
(https://sam.gov/opp/a7865069fb4b4671a0e1a202030fb719/view)
 

Place of Performance

Address: New York, NY 10017, USA

Zip Code: 10017

Country: USA
 

Record

SN06507762-F 20221104/221102230051 (samdaily.us)
 

Source

SAM.gov Link to This Notice
(may not be valid after Archive Date)

---

| FSG Index  |  This Issue's Index  |  Today's SAM Daily Index Page |